A Study of Danavorexton in Anesthetized Adults
Trial Summary
What is the purpose of this trial?
This trial tests the safety and effects of danavorexton, a drug given to healthy adults, when used with anesthetics. Researchers want to see if it is safe and how it behaves in the body.
Research Team
Study Director
Principal Investigator
Takeda
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single intravenous infusion of danavorexton or placebo after being anesthetized for about 40 minutes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Danavorexton
Find a Clinic Near You
Who Is Running the Clinical Trial?
Takeda
Lead Sponsor
Dr. Naoyoshi Hirota
Takeda
Chief Medical Officer since 2020
MD from University of Tokyo
Christophe Weber
Takeda
Chief Executive Officer since 2015
PhD in Molecular Biology from Université de Montpellier